Skip to main content
Premium Trial:

Request an Annual Quote

Christopher Bernard

Curetis has appointed Christopher Bernard as CEO and president of its newly-formed US subsidiary, Curetis USA. He will be responsible for the development of the new subsidiary based in San Diego, CA, and will lead the marketing and sales initiatives for Curetis in the US. Prior to joining Curetis, Bernard served as chief commercial officer of Epic Sciences. Before his work at Epic Sciences, he served as an officer and senior vice president of sales and marketing at Metabolon.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.